{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:37:56Z","timestamp":1784677076573,"version":"3.55.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1245\/s10434-021-11297-z","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T18:54:06Z","timestamp":1641927246000},"page":"3038-3049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data"],"prefix":"10.1245","volume":"29","author":[{"given":"Shi-Qian","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen-Phong","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"11297_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"11297_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole B, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305.","journal-title":"Lancet Oncol."},{"key":"11297_CR3","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703\u201320.","journal-title":"J Clin Oncol."},{"key":"11297_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/bcr2196","volume":"10","author":"AH Sims","year":"2008","unstructured":"Sims AH, Bartlett JM. Approaches towards expression profiling the response to treatment. Breast Cancer Res. 2008;10:115.","journal-title":"Breast Cancer Res."},{"key":"11297_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/1471-2407-9-285","volume":"9","author":"YY Chen","year":"2009","unstructured":"Chen YY, DeVries S, Anderson J, et al. Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer. 2009;9:285.","journal-title":"BMC Cancer."},{"key":"11297_CR6","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.ejca.2009.04.029","volume":"45","author":"ME Straver","year":"2009","unstructured":"Straver ME, Rutgers EJT, Russell NS, et al. Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. Eur J Cancer. 2009;45:2284\u201392.","journal-title":"Eur J Cancer."},{"key":"11297_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609\u201318.","journal-title":"Lancet Oncol."},{"key":"11297_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455\u201361.","journal-title":"JAMA."},{"key":"11297_CR9","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.","journal-title":"PLoS Med."},{"key":"11297_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139\u201345.","journal-title":"Contemp Clin Trials."},{"key":"11297_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jso.20010","volume":"85","author":"T Aihara","year":"2004","unstructured":"Aihara T, Munakata S, Morino H, Takatsuka Y. Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. J Surg Oncol. 2004;85:77\u201381.","journal-title":"J Surg Oncol."},{"key":"11297_CR12","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","volume":"9","author":"R Alvarado","year":"2012","unstructured":"Alvarado R, Yi M, Le-Petross H, et al. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol. 2012;9:3177\u201384.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.breast.2016.07.003","volume":"29","author":"D Andreis","year":"2016","unstructured":"Andreis D, Bonardi S, Allevi G, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer. Breast. 2016;29:55\u201361.","journal-title":"Breast."},{"key":"11297_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13193-020-01035-4","volume":"11","author":"R Arjunan","year":"2020","unstructured":"Arjunan R, Ramamani TA, Ramachandra C, et al. Sentinel lymph node biopsy in locally advanced breast cancer after neoadjuvant chemotherapy: an Indian perspective. Indian J Surg Oncol. 2020;11:242\u20137.","journal-title":"Indian J Surg Oncol."},{"key":"11297_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258\u201364.","journal-title":"J Clin Oncol."},{"key":"11297_CR16","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1200\/JCO.2000.18.20.3480","volume":"18","author":"TM Breslin","year":"2000","unstructured":"Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480\u20136.","journal-title":"J Clin Oncol."},{"key":"11297_CR17","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/cncr.25066","volume":"116","author":"AS Brown","year":"2010","unstructured":"Brown AS, Hunt KK, Shen J, et al. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer. 2010;116:2878\u201383.","journal-title":"Cancer."},{"key":"11297_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ejso.2011.05.012","volume":"37","author":"G Canavese","year":"2011","unstructured":"Canavese G, Dozin B, Vecchio C, et al. Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes. Eur J Surg Oncol. 2011;37:688\u201394.","journal-title":"Eur J Surg Oncol."},{"key":"11297_CR19","first-page":"221","volume":"35","author":"D Carrera","year":"2016","unstructured":"Carrera D, de la Flor M, Galera J, et al. Validation of sentinel lymph node biopsy in breast cancer women N1\u2013N2 with complete axillary response after neoadjuvant chemotherapy: multicentre study in Tarragona. Rev Esp Med Nucl Imagen Mol. 2016;35:221\u20135.","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"11297_CR20","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34:1072\u20138.","journal-title":"J Clin Oncol."},{"key":"11297_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7819-9-19","volume":"9","author":"TM Chintamani","year":"2011","unstructured":"Chintamani TM, Mishra A, Agarwal U, Saxena S. Sentinel lymph node biopsy using dye-alone method is reliable and accurate even after neoadjuvant chemotherapy in locally advanced breast cancer: a prospective study. World J Surg Oncol. 2011;9:19.","journal-title":"World J Surg Oncol."},{"key":"11297_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4048\/jbc.2018.21.e54","volume":"21","author":"HJ Choi","year":"2018","unstructured":"Choi HJ, Kim I, Alsharif E, et al. Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer in diagnosis. J Breast Cancer. 2018;21:433\u201341.","journal-title":"J Breast Cancer."},{"key":"11297_CR23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","volume":"27","author":"JM Classe","year":"2009","unstructured":"Classe JM, Bordes V, Campion L, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol. 2009;27:726\u201332.","journal-title":"J Clin Oncol."},{"key":"11297_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","volume":"173","author":"JM Classe","year":"2019","unstructured":"Classe JM, Loaec C, Gimbergues P, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173:343\u201352.","journal-title":"Breast Cancer Res Treat."},{"key":"11297_CR25","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/00000478-200009000-00010","volume":"24","author":"LF Cohen","year":"2000","unstructured":"Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000;24:1266\u201372.","journal-title":"Am J Surg Pathol."},{"key":"11297_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.clbc.2016.02.009","volume":"16","author":"K Enokido","year":"2016","unstructured":"Enokido K, Watanabe C, Nakamura S, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with an initial diagnosis of cytology-proven lymph node-positive breast cancer. Clin Breast Cancer. 2016;16:299\u2013304.","journal-title":"Clin Breast Cancer."},{"key":"11297_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/00006231-200104000-00003","volume":"22","author":"A Fern\u00e1ndez","year":"2001","unstructured":"Fern\u00e1ndez A, Cort\u00e9s M, Benito E, et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun. 2001;22:361\u20136.","journal-title":"Nucl Med Commun."},{"key":"11297_CR28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1245\/s10434-007-9759-z","volume":"15","author":"P Gimbergues","year":"2008","unstructured":"Gimbergues P, Abrial C, Durando X, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol. 2008;15:1316\u201321.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4048\/jbc.2013.16.4.378","volume":"16","author":"A Han","year":"2013","unstructured":"Han A, Moon HG, Kim J, et al. Reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer. 2013;16:378\u201385.","journal-title":"J Breast Cancer."},{"key":"11297_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijsu.2009.04.012","volume":"7","author":"S Hidar","year":"2009","unstructured":"Hidar S, Bibi M, Gharbi O, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg. 2009;7:272\u20135.","journal-title":"Int J Surg."},{"key":"11297_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00595-007-3686-2","volume":"38","author":"M Hino","year":"2008","unstructured":"Hino M, Sano M, Sato N, Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today. 2008;38:585\u201391.","journal-title":"Surg Today."},{"key":"11297_CR32","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","volume":"250","author":"KK Hunt","year":"2009","unstructured":"Hunt KK, Yi M, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009;250:558\u201366.","journal-title":"Ann Surg."},{"key":"11297_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amjsurg.2005.06.004","volume":"190","author":"JL Jones","year":"2005","unstructured":"Jones JL, Zabicki K, Christian RL, et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg. 2005;190:517\u201320.","journal-title":"Am J Surg."},{"key":"11297_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0002-9610(02)00955-8","volume":"184","author":"TB Julian","year":"2002","unstructured":"Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2002;184:315\u20137.","journal-title":"Am J Surg."},{"key":"11297_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0002-9610(01)00736-X","volume":"182","author":"TB Julian","year":"2001","unstructured":"Julian TB, Patel N, Dusi D, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2001;182:407\u201310.","journal-title":"Am J Surg."},{"key":"11297_CR36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00268-004-7367-7","volume":"28","author":"SH Kang","year":"2004","unstructured":"Kang SH, Kim SK, Kwon Y, et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg. 2004;28:1019\u201324.","journal-title":"World J Surg."},{"key":"11297_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejso.2014.10.066","volume":"41","author":"K Kida","year":"2015","unstructured":"Kida K, Ishikawa T, Yamada A, et al. A prospective feasibility study of sentinel node biopsy by modified indigo carmine blue dye methods after neoadjuvant chemotherapy for breast cancer. Eur J Surg Oncol. 2015;41:566\u201370.","journal-title":"Eur J Surg Oncol."},{"key":"11297_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4048\/jbc.2015.18.1.22","volume":"18","author":"JY Kim","year":"2015","unstructured":"Kim JY, Kim MK, Lee JE, et al. Sentinel lymph node biopsy alone after neoadjuvant chemotherapy in patients with initial cytology-proven axillary node metastasis. J Breast Cancer. 2015;18:22\u20138.","journal-title":"J Breast Cancer."},{"key":"11297_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2325\/jbcs.14.10","volume":"14","author":"T Kinoshita","year":"2007","unstructured":"Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer. 2007;14:10\u20135.","journal-title":"Breast Cancer."},{"key":"11297_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.amjsurg.2005.06.049","volume":"191","author":"T Kinoshita","year":"2006","unstructured":"Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg. 2006;191:225\u20139.","journal-title":"Am J Surg."},{"key":"11297_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/000313481408000226","volume":"80","author":"SB Koslow","year":"2014","unstructured":"Koslow SB, Eisenberg RE, Qiu Q, Chen Z, Swistel A, Shin SJ. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer. Am Surg. 2014;80:171\u20137.","journal-title":"Am Surg."},{"key":"11297_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4143\/crt.2013.208","volume":"47","author":"HD Lee","year":"2015","unstructured":"Lee HD, Ahn SG, Lee SA, Lee HM, Jeong J. Prospective evaluation of the feasibility of sentinel lymph node biopsy in breast cancer patients with negative axillary conversion after neoadjuvant chemotherapy. Cancer Res Treat. 2015;47:26\u201333.","journal-title":"Cancer Res Treat."},{"key":"11297_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-006-9330-9","volume":"102","author":"S Lee","year":"2007","unstructured":"Lee S, Kim EY, Kang SH, et al. Sentinel node identification rate, but not accuracy, is significantly decreased after preoperative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat. 2007;102:283\u20138.","journal-title":"Breast Cancer Res Treat."},{"key":"11297_CR44","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23:2694\u2013702.","journal-title":"J Clin Oncol."},{"key":"11297_CR45","first-page":"390","volume":"60","author":"H Medina-Franco","year":"2008","unstructured":"Medina-Franco H, Salgado-Nesme N, Zer\u00f3n-Medina-Cuair\u00e1n J. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial. Rev Invest Clin. 2008;60:390\u20134.","journal-title":"Rev Invest Clin."},{"key":"11297_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejogrb.2018.06.040","volume":"229","author":"O Najim","year":"2018","unstructured":"Najim O, Dockx Y, Huyghe I, et al. The predictive value of sentinel node biopsy in early breast cancer after neoadjuvant chemotherapy: a prospective study. Eur J Obstet Gynecol Reprod Biol. 2018;229:108\u201311.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"11297_CR47","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","volume":"14","author":"EA Newman","year":"2007","unstructured":"Newman EA, Sabel MS, Nees AV, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol. 2007;14:2946\u201352.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejso.2009.10.015","volume":"36","author":"V Ozmen","year":"2010","unstructured":"Ozmen V, Unal ES, Muslumanoglu ME, et al. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol. 2010;36:23\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"11297_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jso.21128","volume":"98","author":"MZ Papa","year":"2008","unstructured":"Papa MZ, Zippel D, Kaufman B, et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol. 2008;98:403\u20136.","journal-title":"J Surg Oncol."},{"key":"11297_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4143\/crt.2017.210","volume":"50","author":"S Park","year":"2018","unstructured":"Park S, Koo JS, Kim GM, et al. Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Cancer Res Treat. 2018;50:801\u201312.","journal-title":"Cancer Res Treat."},{"key":"11297_CR51","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.clbc.2016.06.020","volume":"17","author":"S Park","year":"2017","unstructured":"Park S, Lee JE, Paik HJ, et al. Feasibility and prognostic effect of sentinel lymph node biopsy after neoadjuvant chemotherapy in cytology-proven, node-positive breast cancer. Clin Breast Cancer. 2017;17:e19-29.","journal-title":"Clin Breast Cancer."},{"key":"11297_CR52","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","volume":"20","author":"S Park","year":"2013","unstructured":"Park S, Park JM, Cho JH, Park HS, Kim SI, Park BW. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Ann Surg Oncol. 2013;20:2858\u201365.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/000313480407000808","volume":"70","author":"NA Patel","year":"2004","unstructured":"Patel NA, Piper G, Patel JA, Malay MB, Julian TB. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer. Am Surg. 2004;70:696\u20139.","journal-title":"Am Surg."},{"key":"11297_CR54","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1002\/cncr.26102","volume":"117","author":"V Pecha","year":"2011","unstructured":"Pecha V, Kolarik D, Kozevnikova R, et al. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Cancer. 2011;117:4606\u201316.","journal-title":"Cancer."},{"key":"11297_CR55","first-page":"19","volume":"50","author":"G P\u00e9ley","year":"2006","unstructured":"P\u00e9ley G, T\u00f6r\u00f6k K, Farkas E, et al. The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer. Magy Onkol. 2006;50:19\u201323.","journal-title":"Magy Onkol."},{"key":"11297_CR56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/ejso.2002.1349","volume":"29","author":"JR Piato","year":"2003","unstructured":"Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy: a pilot study. Eur J Surg Oncol. 2003;29:118\u201320.","journal-title":"Eur J Surg Oncol."},{"key":"11297_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ciresp.2014.01.004","volume":"93","author":"A Pi\u00f1ero-Madrona","year":"2015","unstructured":"Pi\u00f1ero-Madrona A, Escudero-Barea MJ, Fern\u00e1ndez-Robayna F, et al. Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005\u201307 study. Cir Esp. 2015;93:23\u20139.","journal-title":"Cir Esp."},{"key":"11297_CR58","first-page":"117","volume":"31","author":"AC Rebollo-Aguirre","year":"2012","unstructured":"Rebollo-Aguirre AC, Gallego-Peinado M, Menj\u00f3n-Beltr\u00e1n S, et al. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy. Rev Esp Med Nucl Imagen Mol. 2012;31:117\u201323.","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"11297_CR59","first-page":"240","volume":"32","author":"AC Rebollo-Aguirre","year":"2013","unstructured":"Rebollo-Aguirre AC, Gallego-Peinado M, S\u00e1nchez-S\u00e1nchez R, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis. Rev Esp Med Nucl Imagen Mol. 2013;32:240\u20135.","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"11297_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jso.10294","volume":"84","author":"R Reitsamer","year":"2003","unstructured":"Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol. 2003;84:63\u20137.","journal-title":"J Surg Oncol."},{"key":"11297_CR61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1046\/j.1524-4741.2003.09502.x","volume":"9","author":"GF Schwartz","year":"2003","unstructured":"Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J. 2003;9:374\u20139.","journal-title":"Breast J."},{"key":"11297_CR62","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/cncr.24887","volume":"116","author":"GF Schwartz","year":"2010","unstructured":"Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Cancer. 2010;116:1243\u201351.","journal-title":"Cancer."},{"key":"11297_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02573060","volume":"9","author":"VCARMFDFTN tearnsEwingSlackPenannenHayesTsanga","year":"2002","unstructured":"tearnsEwingSlackPenannenHayesTsangaris VCARMFDFTN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002;9:235\u201342.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-020-05559-9","volume":"180","author":"X Sun","year":"2020","unstructured":"Sun X, Wang XE, Zhang ZP, et al. Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial. Breast Cancer Res Treat. 2020;180:423\u20138.","journal-title":"Breast Cancer Res Treat."},{"key":"11297_CR65","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s00268-012-1704-z","volume":"36","author":"M Takahashi","year":"2012","unstructured":"Takahashi M, Jinno H, Hayashida T, Sakata M, Asakura K, Kitagawa Y. Correlation between clinical nodal status and sentinel lymph node biopsy false-negative rate after neoadjuvant chemotherapy. World J Surg. 2012;36:2847\u201352.","journal-title":"World J Surg."},{"key":"11297_CR66","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10147-012-0418-4","volume":"18","author":"H Takei","year":"2013","unstructured":"Takei H, Yoshida T, Kurosumi M, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation. Int J Clin Oncol. 2013;18:547\u201353.","journal-title":"Int J Clin Oncol."},{"key":"11297_CR67","first-page":"927","volume":"15","author":"Y Tanaka","year":"2006","unstructured":"Tanaka Y, Maeda H, Ogawa Y, et al. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Oncol Rep. 2006;15:927\u201331.","journal-title":"Oncol Rep."},{"key":"11297_CR68","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1245\/s10434-008-0041-9","volume":"15","author":"C Tausch","year":"2008","unstructured":"Tausch C, Konstantiniuk P, Kugler F, et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol. 2008;15:3378\u201383.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.clbc.2013.08.014","volume":"13","author":"H Yagata","year":"2013","unstructured":"Yagata H, Yamauchi H, Tsugawa K, et al. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Clin Breast Cancer. 2013;13:471\u20137.","journal-title":"Clin Breast Cancer."},{"key":"11297_CR70","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/000313480707301010","volume":"73","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto M, Mehta RS, Baick CH, et al. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy. Am Surg. 2007;73:977\u201380.","journal-title":"Am Surg."},{"key":"11297_CR71","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1245\/s10434-006-9132-7","volume":"14","author":"JC Yu","year":"2007","unstructured":"Yu JC, Hsu GC, Hsieh CB, Yu CP, Chao TY. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol. 2007;14:174\u201380.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR72","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12885-016-2829-5","volume":"16","author":"Y Yu","year":"2016","unstructured":"Yu Y, Cui N, Li HY, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration. BMC Cancer. 2016;16:808.","journal-title":"BMC Cancer."},{"key":"11297_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","volume":"163","author":"LH Zetterlund","year":"2017","unstructured":"Zetterlund LH, Frisell J, Zouzos A, et al. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer. Breast Cancer Res Treat. 2017;163:103\u201310.","journal-title":"Breast Cancer Res Treat."},{"key":"11297_CR74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12094-012-0885-0","volume":"15","author":"GC Zhang","year":"2013","unstructured":"Zhang GC, Liao N, Guo ZB, et al. Accuracy and axilla-sparing potentials of sentinel lymph node biopsy with methylene blue alone performed before versus after neoadjuvant chemotherapy in breast cancer: a single-institution experience. Clin Transl Oncol. 2013;15:79\u201384.","journal-title":"Clin Transl Oncol."},{"key":"11297_CR75","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00404-020-05646-8","volume":"302","author":"X Wu","year":"2020","unstructured":"Wu X, Tang L, Huang W, Huang S, Peng W, Hu D. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer. Arch Gynecol Obstet. 2020;302:685\u201392.","journal-title":"Arch Gynecol Obstet."},{"key":"11297_CR76","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1200\/GO.20.00246","volume":"6","author":"V Parmar","year":"2020","unstructured":"Parmar V, Nair NS, Vanmali V, et al. Sentinel node biopsy versus low axillary sampling in predicting nodal status of postchemotherapy axilla in women with breast cancer. JCO Glob Oncol. 2020;6:1546\u201353.","journal-title":"JCO Glob Oncol."},{"key":"11297_CR77","first-page":"e83946","volume":"11","author":"H Yahyazadeh","year":"2018","unstructured":"Yahyazadeh H, Hashemian M, Rajabpour M, et al. The accuracy of sentinel lymph node biopsy following neoadjuvant chemotherapy in clinically node-positive breast cancer patients: a single-institution experience. Int J Cancer Manag. 2018;11:e83946.","journal-title":"Int J Cancer Manag."},{"key":"11297_CR78","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/1759-7714.12131","volume":"5","author":"WK Ge","year":"2014","unstructured":"Ge WK, Yang B, Zuo WS, et al. Sentinel lymph node biopsy does not apply to all axillary lymph node-positive breast cancer patients after neoadjuvant chemotherapy. Thorac Cancer. 2014;5:550\u20135.","journal-title":"Thorac Cancer."},{"key":"11297_CR79","first-page":"866","volume":"40","author":"T Fu","year":"2014","unstructured":"Fu T, Zhang S, Zhang HP, et al. Evaluation on feasibility of sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Jilin Univ Med Ed. 2014;40:866\u20139.","journal-title":"J Jilin Univ Med Ed."},{"key":"11297_CR80","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10330-013-1251-6","volume":"12","author":"J Xu","year":"2013","unstructured":"Xu J, Wu X, Feng Y, Yuan F, Fan W. The clinical significance of axillary sentinel lymph node biopsy in different clinical stages breast cancer patients after neoadjuvant chemotherapy. Chin Ger J Clin Oncol. 2013;12:521\u20133.","journal-title":"Chin Ger J Clin Oncol."},{"key":"11297_CR81","first-page":"1883","volume":"19","author":"R Pan","year":"2012","unstructured":"Pan R, Yang B, Zuo WS, et al. Clinical value of sentinel lymph node biopsy for the breast cancer patients receiving neoadjuvant chemotherapy. Chinese J Cancer Prev Treat. 2012;19:1883\u20138.","journal-title":"Chinese J Cancer Prev Treat."},{"key":"11297_CR82","first-page":"217","volume":"24","author":"JP Colmenares","year":"2012","unstructured":"Colmenares JP, M\u00e1rquez PL, Chacin B, Castillo L. Sentinel lymph node detection with patent blue dye of locally advanced breast cancer after neoadjuvant chemotherapy. Rev Venez de Oncol. 2012;24:217\u201325.","journal-title":"Rev Venez de Oncol."},{"key":"11297_CR83","first-page":"1949","volume":"16","author":"ZK Sun","year":"2009","unstructured":"Sun ZK, Ma XT, Chen ZJ, Wan XH, Wang Q, Fun AR. Prospective study of axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Chinese J Cancer Prev Treat. 2009;16:1949\u201352.","journal-title":"Chinese J Cancer Prev Treat."},{"key":"11297_CR84","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1445-2197.2009.05057.x","volume":"79","author":"TT Cheung","year":"2009","unstructured":"Cheung TT, Suen DTK, Kwong A. Is sentinel lymph node biopsy after neoadjuvant chemotherapy feasible in Chinese patients with invasive breast cancers? ANZ J Surg. 2009;79:719\u201323.","journal-title":"ANZ J Surg."},{"key":"11297_CR85","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#","volume":"89","author":"KS Nason","year":"2000","unstructured":"Nason KS, Anderson BO, Byrd DR, et al. Increased false-negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 2000;89:2187\u201394.","journal-title":"Cancer."},{"key":"11297_CR86","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02573061","volume":"9","author":"AR Miller","year":"2002","unstructured":"Miller AR, Thomason VE, Yeh IT, et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol. 2002;9:243\u20137.","journal-title":"Ann Surg Oncol."},{"key":"11297_CR87","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/cncr.20242","volume":"100","author":"K Shimazu","year":"2004","unstructured":"Shimazu K, Tamaki Y, Taguchi T, Akazawa K, Inoue T, Noguchi S. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer. 2004;100:2555\u201361.","journal-title":"Cancer."},{"key":"11297_CR88","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/bjs.10986","volume":"105","author":"SR Tee","year":"2018","unstructured":"Tee SR, Devane LA, Evoy D, et al. Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer. Br J Surg. 2018;105:1541\u201352.","journal-title":"Br J Surg."},{"key":"11297_CR89","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","volume":"269","author":"JM Simons","year":"2019","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, Luiten EJT, Koppert LB, Smidt ML. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2019;269:432\u201342.","journal-title":"Ann Surg."},{"key":"11297_CR90","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","volume":"48","author":"N Houssami","year":"2012","unstructured":"Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012;48:3342\u201354.","journal-title":"Eur J Cancer."},{"key":"11297_CR91","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881\u20138.","journal-title":"Lancet Oncol."},{"key":"11297_CR92","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1072-7515(01)00858-4","volume":"192","author":"SL Wong","year":"2001","unstructured":"Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192:684\u20139.","journal-title":"J Am Coll Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-11297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-11297-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-11297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T16:35:52Z","timestamp":1674405352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-11297-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["11297"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-11297-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}